t

Controversial treatment for dwarfism meets clinical trial goals. Is FDA approval coming?

Damian Garde | 
A treatment for the most common cause of dwarfism met its goal of increasing height in a pivotal study, the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists